Cannabis Law Report

FEBRUARY 1, 2022

Bod Australia has announced its planned phase IIB clinical trial of a cannabis extract with insomnia patients has received ethics approval. The trial will investigate the efficacy of a new prospective Schedule 3 CBD (cannabidiol) formulation on insomnia symptoms.

Clinical Trials 59

Clinical Trials CBD Medicine Extraction 59

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7 billion in 2030. 2 Pain 1994 Apr;57(1):5-15. 3 Psychol Res Behav Manag.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

FEBRUARY 24, 2022

Thus, providing a new pathway for patients to access psychedelic treatment, and another example of the medicinal approach to psychedelic legalization. Timeline of Medicinal Legalization in Canada. The changes to the FDR and CDSA do not outright legalize MDMA or psilocybin for medicinal use. Subsection 56(1) Exemption.

Therapy 52

Therapy Access Clinical Trials Treatment 52

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. In Western medicine, the psychedelic revolution is coming at the perfect moment as the country grapples with a post-COVID world.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

The Cannigma

JUNE 14, 2021

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

SEPTEMBER 1, 2021

CYBN ) is a Toronto-based psychedelic medicine firm. Going public in November 2020 on the NEO exchange, the firm has been steadily growing its market cap and development pipeline. At the moment, MindMed is hands-down the industry leader in LSD-inspired medicines. Mind Medicine Inc. ( MNMD ) is an industry leader.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

MARCH 29, 2022

NZ’s Greenfern Industries say it is the first New Zealand medicinal cannabis company to be awarded B Corp certification. carbonzero certified medicinal cannabis and industrial hemp company. Rebuilt in 2008, Greenfern’s crowdfunding campaign in 2020 enabled the firm to buy the power station outright. So, what is a “ B Corp “?

Clinical Trials 52

Clinical Trials Medicine Environment Consumption 52

Cannabis Law Report

MAY 29, 2022

The company has been building its two adjacent 10,000 square foot facilities since August 2020. This is a natural medicine. They’re creating medicine synthetically, and giving it to people to do exactly what this can do. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

The Cannigma

OCTOBER 14, 2022

In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. San Marino is a mountainous microstate that is enclosed by Italy on all sides. San Marino medical marijuana program. Is CBD legal in San Marino?

Law 56

Law Clinical Trials Research and Development Recreational 56

The Cannigma

MARCH 18, 2021

The study was compiled by way of an anonymous email survey sent to 7,607 people with Parkinson’s disease in January 2020. An overwhelming 84.7% said that cannabis use had no impact on prescription medication usage, and 89% said they had not thought that cannabis would replace their prescription medications for Parkinson’s Disease.

Patients 138

Patients Clinical Trials Treatment Cannabis 138

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). In 2020, Goldfinch Bio was named one of Fierce Biotech’s “Fierce 15” companies.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

The Cannigma

MAY 19, 2021

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137

Law Legalization Clinical Trials CBD 137

Veriheal

NOVEMBER 17, 2020

According to the Ohio State Medical Marijuana website, the petition will not be considered if received after December 31, 2020, if it seeks to add a broad category of diseases or conditions, or if the condition is one that has been previously reviewed by the board and rejected unless new scientific research that supports the request is offered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Cannabis Law Report

JULY 9, 2021

In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. On November 3, 2020, Oregon became the first state to decriminalize psilocybin for recreational purposes. Id ; 21 CFR 312.1-10; 10; 312.80-88; 88; 312.300 et seq.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 18, 2019

…MGC Pharmaceuticals has achieved yet another significant milestone with the bio-pharma company this week surpassing more than 1,800 prescribed products of its medicinal cannabis-based pharmaceutical products in Australia, UK, Brazil and Ireland. The West Australian reports.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

OCTOBER 13, 2021

Vigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

Veriheal

JULY 12, 2021

A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression. A 2020 study found that all symptoms of PTSD were reduced by more than 50% immediately after cannabis consumption. What Is The Latest Research for Veterans and PTSD?

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

AUGUST 25, 2021

“The acquisition of a distinctive company like Lucid illustrates FSD Pharma’s vision to build a portfolio of biotechnology assets on a new frontier of medicine that hold the potential to treat mental health disorders and neurodegenerative diseases in a new way,” said Anthony Durkacz, Interim CEO of FSD Pharma. Strategic Highlights.

Clinical Trials 111

Clinical Trials Research and Development Therapy Conditions 111

The Cannigma

AUGUST 26, 2021

percent), according to the United Nations World Drug Report for 2020.In In addition, a survey published in July 2020 found that 41% of Australians support cannabis legalization, and 37% are opposed. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JUNE 25, 2021

billion in 2020 to $1.61 The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. Global Skin Cancer Drugs Historic Market, 2015-2020, $ Billion. Actinic Keratoses (AK). Chemotherapy.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. n) any related matters.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

MARCH 22, 2020

Aurelius Data, a company dedicated to providing data around plant-based medicines, warned the public Tuesday that THC and COVID-19 don’t mix, based on what they know about how cannabinoids affect patients with influenza. 9:46 AM – Mar 19, 2020. Twitter Ads info and privacy. 7,739 people are talking about this.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Law Report

DECEMBER 14, 2019

Here’s the spruik…… Since then, Australia’s medicinal marijuana industry has been hit by the slump currently dragging down marijuana markets across the world. Despite the struggles of the stock market, the local industry has picked up thanks to the rush of new medicinal marijuana products becoming available to consumers.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

OCTOBER 26, 2021

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. Dr. Chapman Bio. Chapman has operated Chapman Pharmaceutical Consulting, Inc.,

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 24, 2019

We are pleased to share with you that earlier this fall, the Center for Psychedelic and Consciousness Research was founded at the Johns Hopkins School of Medicine. Scientific American recently outlined the legal implications surrounding psychedelic medicine. February 18, 2020. February 28, 2020. February 29, 2020.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

Healer

MARCH 26, 2021

It’s estimated that 2020 spending was about $48 million. . Funding for all research into cannabis also has increased, from $111 million in 2015 to an estimated $196 million in 2020. . Opioids are a good medicine. The researchers stressed the need for large, well-designed clinical trials. WHAT ABOUT CBD?

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO). Dr. Jacobs, who most recently served as CSO of Ardelyx, Inc.,

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. Acceptance of Medicinal Cannabis. National legalisation of medical cannabis could occur as early as 2020 in Spain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

SEPTEMBER 6, 2021

The global medical cannabis market exhibited strong growth during 2015-2020. It was used medicinally in ancient Indian, Chinese, Egyptian and Islamic cultures. Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 649, 654 (2020). Except for ketamine, an essential medicine used in anesthesia, 6 × 6. Trial of Psilocybin Versus Escitalopram for Depression , 384 NEW ENG. Quibell et al., supra note 2, at 640.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. Acceptance of Medicinal Cannabis. National legalisation of medical cannabis could occur as early as 2020 in Spain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Glaucoma is still the first condition many people think of when they consider cannabis as a medicine. Medicinal Cannabis—Potential Drug Interactions.” Medicines 6.1

CBD 98

CBD THC Conditions Medicine 98

The Joint Blog

FEBRUARY 24, 2021

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. Though trialing is relatively new and there is no clear scientific evidence as of yet, anecdotal evidence from patients is looking positive.

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Cannigma

SEPTEMBER 21, 2021

In 2019, Stewart called on the UK government to ease the restrictions surrounding cannabis-based medicines, and said in a statement that “the moment I started using cannabis-based cream it worked and I could feel an immediate reduction in discomfort. It meant I could grip my hands and hook my thumb around the steering wheel of a car again.

Patients 94

Patients Research and Development Sleep Clinical Trials 94